Patient Guide: A Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Briquilimab in Participants With Allergic Asthma

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 6 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06592768
Status: ACTIVE_NOT_RECRUITING
Condition: Allergic Asthma
Phase: PHASE1

Where You Can Participate

This study is available at 6 locations across the country.

Top locations include:
  • • Calgary, Alberta
  • • Edmonton, Alberta
  • • Vancouver, British Columbia
  • • And 3 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Briquilimab in Participants With Allergic Asthma - Join Clinical Trial NCTNCT06592768

How to Join This Clinical Trial - NCTNCT06592768

Learn how to participate in this PHASE1 trial studying an investigational therapy for Allergic Asthma. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Allergic Asthma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Allergic Asthma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT06592768 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 6 locations. Find a study site near you:

Clinical Research Site

Calgary, Alberta T2N 1N4 - Canada

Status: Contact for availability

Clinical Research Site

Edmonton, Alberta T6G 2R3 - Canada

Status: Contact for availability

Clinical Research Site

Vancouver, British Columbia V6T 1Z4 - Canada

Status: Contact for availability

Clinical Research Site

Hamilton, Ontario L8N 3Z5 - Canada

Status: Contact for availability

Clinical Research Site

Quebec City, Quebec G1V 0A6 - Canada

Status: Contact for availability

Clinical Research Site

Saskatoon, Saskatchewan S7N 5A2 - Canada

Status: Contact for availability

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for Allergic Asthma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships